Identification of NS5B resistance-associated mutations in hepatitis C virus circulating in treatment-naïve Cameroonian patients
Our investigation revealed that HCV patients who had not previously received DAA therapy exhibited a variety of NS5B gene alterations. Consequently, future treatment failure may be more likely due to these alterations.
Authors
- Simon Frédéric Lissock
- Chavely Gwladys Monamele (ORCID: https://orcid.org/0000-0002-2637-2078)
- Richard Njouom (ORCID: https://orcid.org/0000-0003-3112-6370)
- Paul Alain Tagnouokam‐Ngoupo (ORCID: https://orcid.org/0000-0002-7449-5128)
- Jean Paul Assam Assam (ORCID: https://orcid.org/0000-0001-6601-2934)
- Abdou Fatawou Modiyinji (ORCID: https://orcid.org/0000-0001-6706-3012)
- Pretty Rosereine Mbouyap
- Aristide Mounchili-Njifon
- Moise Henri Moumbeket-Yifomnjou
- Gisèle Liliane Machuetum
- Philipe Herman Njitoyap Mfombouot
- Pascal Ibrahim Toueyem
Institutions
- Université de Yaoundé I (CM)
- Centre Pasteur du Cameroun (CM)
Publication Details
- Journal
- IJID Regions
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1016/j.ijregi.2025.100816
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00